Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hofseth Biocare ASA ( (HOFBF) ) just unveiled an announcement.
Hofseth BioCare ASA successfully held its Annual General Meeting on May 23, 2025, where all proposals were approved. This meeting reinforces the company’s strategic direction and ongoing commitment to innovation in health products derived from salmon by-products, potentially impacting its market position and stakeholder interests positively.
More about Hofseth Biocare ASA
Hofseth BioCare ASA is a Norwegian company specializing in consumer and pet health products, focusing on sustainability and the optimal use of natural resources. The company converts salmon industry by-products into health-improving ingredients, such as ProGo®, OmeGo®, and CalGo®, which offer various health benefits. HBC is committed to scientific research, resulting in academic partnerships, patents, and the establishment of a biotech company, HBC Immunology, targeting cancer and asthma therapies.
Average Trading Volume: 73,947
Current Market Cap: NOK924.9M
See more insights into HOFBF stock on TipRanks’ Stock Analysis page.